Popular Articles

King And Pain Therapeutics Announce REMOXY(R) NDA Update
King Pharmaceuticals, Inc. (NYSE: KG) and Pain Therapeutics, Inc. (Nasdaq: PTIE) announced that on July 2, 2009, King met with the US Food and Drug Administration (FDA) to discuss the Complete Response Letter regarding the New Drug Application (NDA) for REMOXY(R). The outcome of this meeting provided King with a clear path forward to resubmit the REMOXY(R) NDA and to address all FDA comments in the Complete Response Letter.

Number Of Polio Cases In Nigeria Decreases, Some States Still Showing Low Immunizations Rates
The number of polio cases in Nigeria has gone down from 799 in 2008 to 353 this year, according to the country"s National Primary Health Care Development Agency (NPHCDA), Africa Science News Service reports. The number of children who have never had a polio vaccine has been reduced from 16 percent in 2008 to 8 percent in 2009, NPHCDA Executive Director Mohammed Ali Pate said.
News of the day
Prospective Evaluation Finds High Levels Of Satisfaction With ConvaTec Moldable Skin Barrier
Enterostomal therapy nurses and people living with an ostomy reported very high levels of satisfaction with a new moldable skin barrier pioneered by ConvaTec Ostomy Care, according to results from a prospective evaluation published this month in the journal Ostomy Wound Management.
Endocrinology

Male Circumcision Does Not Appear To Reduce HIV Transmission Risk To Female Partners

Although several studies have shown that circumcision, removal of the foreskin which contains cells that are particularly susceptible to HIV, appears to reduce a man"s risk of contracting HIV from his female sex partner, it does not reduce the female sex partners" risk of contracting the virus, according to a study in the Lancet, Reuters reports. Maria Wawer of Johns Hopkins University and colleagues in Uganda followed 922 HIV-positive, uncircumcised men ages 15 to 49. Some of the men immediately underwent a circumcision, and some had the procedure two years later. The researchers also followed 163 female partners of the men.The researchers decided to end the study early when they found that male circumcision did not convey the expected benefits to women. The study also found that men"s partners were no less likely to contract other sexually transmitted infections, except for trichomonas.However, based on observational studies, researchers say that circumcision is so effective in protecting men that it will still likely benefit women indirectly by reducing circulation of the virus in general (Fox, Reuters, 7/16). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):